1月18日的Multiple Myeloma Management应用程序分析
Multiple Myeloma Management
- UMA MLG, LLC
- Apple 应用商店
- 免费
- 医疗
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
商店排名
商店排名基于 Google 和 Apple 设置的多个参数。
所有品类在
美国--
医疗在
美国--
![Multiple Myeloma [MM]](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/dc/6e/02/dc6e0221-54cd-776e-d0f9-cdddc953da3f/AppIcon-0-0-1x_U007epad-0-11-0-85-220.png/175x175bb.jpg){kind=small}
Multiple Myeloma Management VS. 一月 18, 2026